研究者業績

向井 宏樹

ムカイ ヒロキ  (Hiroki Mukai)

基本情報

所属
千葉大学 医学部附属病院 助教
学位
医学博士(2016年3月 千葉大学)

研究者番号
70748748
J-GLOBAL ID
202201005925815007
researchmap会員ID
R000032803

論文

 42
  • Atsuhiko Sugiyama, Yuki Nakagawa, Hiroki Mukai, Hajime Yokota, Fumiko Oda, Ayano Yamaguchi, Kazuki Ishiwata, Shintaro Izumi, Takashi Matsukawa, Akiyuki Uzawa, Satoshi Kuwabara
    Journal of the neurological sciences 472 123444-123444 2025年3月2日  
  • Sakie Namba, Hajime Yokota, Hiroki Mukai, Jun Hashiba, Naoki Kogayo, Tatsushi Nakao, Atsuhiko Sugiyama, Etsuko Ogaya, Yuya Aotsuka, Satoshi Kuwabara, Takashi Uno
    Radiology case reports 19(5) 1718-1721 2024年5月  
    We report the case of a woman in her 40s who presented with sensory disturbances in all 4 limbs and left facial palsy. MRI revealed asymmetric enlargement of the dorsal root ganglia, which was enhanced by gadolinium-a chest CT scan identified enlarged supraclavicular, mediastinal, and hilar lymph nodes. A biopsy of a hilar lymph node showed noncaseating epithelioid granulomas, confirming a sarcoidosis diagnosis. Prednisolone treatment led to symptomatic improvements. In sarcoidosis of the peripheral nervous system, there might be observable enlargement of the dorsal root ganglion alongside enhanced gadolinium contrast. Obtaining a biopsy from the dorsal root ganglion poses challenges, and radiologists should be mindful of this specific imaging characteristic.
  • Zhihui Tang, Shigeki Hirano, Yume Koizumi, Michiko Izumi, Yoshihisa Kitayama, Kosuke Yamagishi, Mitsuyoshi Tamura, Ai Ishikawa, Kouichi Kashiwado, Takashi Iimori, Hiroki Mukai, Hajime Yokota, Takuro Horikoshi, Takashi Uno, Satoshi Kuwabara
    Journal of Alzheimer's disease : JAD 100(1) 127-137 2024年  
    BACKGROUND: Dementia with Lewy bodies (DLB) presents with various symptoms, posing challenges for early diagnosis challenging. Dopamine transporter (123I-FP-CIT) single-photon emission tomography (SPECT) and 123I-meta-iodobenzylguanidine (123I-MIBG) imaging are crucial diagnostic biomarkers. Hypothesis about body- and brain-first subtypes of DLB indicate that some DLB may show normal 123I-FP-CIT or 123I-MIBG results; but the characteristic expression of these two subtypes remains unclear. OBJECTIVE: This study aimed to evaluate the diagnostic sensitivity of 123I-FP-CIT and 123I-MIBG imaging alone, combined in patients with DLB and explore symptoms associated with the abnormal imaging results. METHODS: Demographic data, clinical status, and imaging results were retrospectively collected from patients diagnosed with possible DLB. Both images were quantified using semi-automated software, and the sensitivity of each imaging modality and their combination was calculated. Demographic data, cognition, and motor and non-motor symptoms were compared among the subgroups based on the imaging results. Symptoms related to each imaging abnormality were examined using binomial logistic regression analyses. RESULTS: Among 114 patients with DLB, 80 underwent 123I-FP-CIT SPECT (sensitivity: 80.3%), 83 underwent 123I-MIBG imaging (68.2%), and 66 both (sensitivity of either abnormal result: 93.9%). Visual hallucinations differed among the four subgroups based on imaging results. Additionally, nocturia and orthostatic hypotension differed between abnormal and normal 123I-MIBG images. CONCLUSIONS: Overall, 123I-FP-CIT SPECT was slightly higher sensitivity than 123I-MIBG imaging, with combined imaging increasing diagnostic sensitivity. Normal results of a single imaging test may not refute DLB. Autonomic symptoms may lead to abnormal 123I-MIBG scintigraphy findings indicating body-first subtype of patients with DLB.
  • Yuki Muroga, Atsuhiko Sugiyama, Hiroki Mukai, Jun Hashiba, Hajime Yokota, Katsuya Satoh, Tetsuyuki Kitamoto, Jiaqi Wang, Shoichi Ito, Satoshi Kuwabara
    Prion 17(1) 105-110 2023年12月  
    The most common genetic Creutzfeldt-Jakob disease (gCJD) in Japan is caused by a point mutation in which isoleucine replaces valine at codon 180 of the prion protein (PrP) gene (V180I gCJD). Evidence suggests that cerebral cortex swelling, which appears as abnormal hyperintensities on diffusion-weighted imaging (DWI), is a characteristic magnetic resonance imaging (MRI) finding of V180I gCJD. However, no study has directly compared the MRI findings between V180I gCJD and sporadic CJD (sCJD). The current study, therefore, aims to clarify the imaging features of V180I gCJD, which would lead to prompt genetic counselling and analysis of the PrP gene, particularly focusing on cerebral cortex swelling. We included 35 patients with sCJD (n = 23) or V180I gCJD (n = 12). Cerebral cortex swelling on T2-weighted imaging (T2WI) or fluid-attenuated inversion recovery (FLAIR) wherein abnormal cortical hyperintensities were observed on DWI, and the distribution of grey matter hyperintensities on DWI were visually evaluated. V180I gCJD patients had significantly more cerebral cortex swelling (100% vs. 13.0%, p < 0.001), an overall correct classification of 91.4%, and parahippocampal gyrus hyperintensities on DWI (100% vs. 39.1%, q = 0.019) than sCJD patients. Cerebral cortical hyperintensities on DWI with swelling on T2WI or FLAIR are characteristic imaging findings of V180I gCJD and are useful for differentiating it from sCJD.

MISC

 104